Pfizer and BioNTech have received a positive CHMP opinion from the European Medicines Agency to administer the coronavirus booster vaccine to people 18 years and older at least 6 months after the second dose. The European Commission will review the CHMP recommendation and make a final decision on changing the conditional marketing authorization in the near future. If approved, the decision will apply to all 27 EU member states.